Next Article in Journal
Cat-Scratch Disease in Crete: An Update
Previous Article in Journal
Hyper-Reactive Malarial Splenomegaly and Splenic Infarct in a Caucasian Toddler
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Infectious Disease Reports
Volume 3
Issue 2
10.4081/idr.2011.e14
idr-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Infectious Disease Reports is published by MDPI from Volume 12 Issue 3 (2020). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Brief Report

Bosentan and Sildenafil in the Treatment of HIV-Associated Pulmonary Hypertension

by
Pierangelo Chinello
1,*,
Stefania Cicalini
1,
Andrea Cortese
2,
Maria Paola Cicini
3 and
Nicola Petrosillo
1
1
Second Infectious Diseases Unit, L. Spallanzani National Institute for Infectious Diseases, Rome, Italy
2
U.O. Diagnostica per Immagini, S. Camillo-Forlanini Hospital, Rome, Italy
3
III Cardiology Unit, S. Camillo-Forlanini Hospital, Rome, Italy
*
Author to whom correspondence should be addressed.
Infect. Dis. Rep. 2011, 3(2), e14; https://doi.org/10.4081/idr.2011.e14
Submission received: 11 August 2011 / Revised: 19 October 2011 / Accepted: 30 October 2011 / Published: 22 November 2011

Abstract

We present the case of an HIV/HCV-coinfected patient with HIV-related pulmonary hypertension (HRPH) who experienced a good clinical and functional response to bosentan, with a subsequent switch to oral sildenafil due to increased transaminase levels. Bosentan resulted less handy in this case, probably due to both side effects and co-morbidities.
Keywords: bosentan; sildenafil; HIV; pulmonary arterial hypertension bosentan; sildenafil; HIV; pulmonary arterial hypertension

Share and Cite

MDPI and ACS Style

Chinello, P.; Cicalini, S.; Cortese, A.; Cicini, M.P.; Petrosillo, N. Bosentan and Sildenafil in the Treatment of HIV-Associated Pulmonary Hypertension. Infect. Dis. Rep. 2011, 3, e14. https://doi.org/10.4081/idr.2011.e14

AMA Style

Chinello P, Cicalini S, Cortese A, Cicini MP, Petrosillo N. Bosentan and Sildenafil in the Treatment of HIV-Associated Pulmonary Hypertension. Infectious Disease Reports. 2011; 3(2):e14. https://doi.org/10.4081/idr.2011.e14

Chicago/Turabian Style

Chinello, Pierangelo, Stefania Cicalini, Andrea Cortese, Maria Paola Cicini, and Nicola Petrosillo. 2011. "Bosentan and Sildenafil in the Treatment of HIV-Associated Pulmonary Hypertension" Infectious Disease Reports 3, no. 2: e14. https://doi.org/10.4081/idr.2011.e14

APA Style

Chinello, P., Cicalini, S., Cortese, A., Cicini, M. P., & Petrosillo, N. (2011). Bosentan and Sildenafil in the Treatment of HIV-Associated Pulmonary Hypertension. Infectious Disease Reports, 3(2), e14. https://doi.org/10.4081/idr.2011.e14

Article Metrics

Back to TopTop